Outcome of medial hamstring lengthening in children with spastic paresis: A biomechanical and morphological observational study by Helga Haberfehlner (3353090)

“…In the majority of children muscle volume of the semitendinosus muscle decreased substantially suggesting a reduction of physiological cross-sectional area. …”

A hypothetical schematic diagram showing molecular events occurs during hypobaric hypoxia in kidney. by Varun Chhabra (5513573)

Supplementary Figures from A Metastatic Mouse Model Identifies Genes That Regulate Neuroblastoma Metastasis by Bo Kyung A. Seong (14926620)

“…Supplementary Figure 4 - CADM1 over-expression decreases migration of SHEP cell line. Supplementary Figure 5 - Verteporfin (VP), a pharmacological inhibitor of YAP, induces apoptosis and decreases migration of metastatic cells in in vitro and inhibits the metastatic phenotype in vivo. …”

Effects of huperzine A on hippocampal inflammatory response and neurotrophic factors in aged rats after anesthesia by Yi Cai (233861)

“…Conclusion HupA may alleviate the cognitive impairment in rats after isoflurane anesthesia by decreasing inflammatory factors and increasing hippocampal neurotrophic factors in hippocampus tissue.…”

Calibrated curve assuming a normal distribution, using bchron in R, and histogram of temple dates. by Sarah Klassen (5931605)

Image_1_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.TIF by Ariel Rechtman (12283325)

“…Background<p>Myelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS. …”

Table_7_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.DOCX by Ariel Rechtman (12283325)

“…Background<p>Myelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS. …”

Image_3_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.TIF by Ariel Rechtman (12283325)

“…Background<p>Myelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS. …”

Table_1_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.DOCX by Ariel Rechtman (12283325)

“…Background<p>Myelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS. …”

Table_8_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.DOCX by Ariel Rechtman (12283325)

“…Background<p>Myelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS. …”

Table_2_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.DOCX by Ariel Rechtman (12283325)

“…Background<p>Myelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS. …”

Table_4_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.DOCX by Ariel Rechtman (12283325)

“…Background<p>Myelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS. …”

Image_2_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.TIF by Ariel Rechtman (12283325)

“…Background<p>Myelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS. …”

Table_6_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.DOCX by Ariel Rechtman (12283325)

“…Background<p>Myelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS. …”

Table_3_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.DOCX by Ariel Rechtman (12283325)

“…Background<p>Myelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS. …”

Table 1_Ferula (Ferula elaeochytris) as a phytoestrogen: Use of Ferula in laying hens.docx by Arda Onur Özkök (20595461)

“…FRP-1 and FRP-2 groups, however, were fed a diet supplemented with 1 g/kg and 2 g/kg FRP, respectively. …”

Table_5_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.DOCX by Ariel Rechtman (12283325)

“…Background<p>Myelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS. …”

Accuracy of test sets for each model, specifically. by Hongwei Bai (1447999)

Image_4_Surprise Acts as a Reducer of Outcome Value in Human Reinforcement Learning.PNG by Motofumi Sumiya (4824993)

“…Here, we propose the surprise-sensitive utility model, a reinforcement learning model that states that surprise decreases the outcome value, to explain how surprise affects subsequent decision making. …”

Image_5_Surprise Acts as a Reducer of Outcome Value in Human Reinforcement Learning.TIFF by Motofumi Sumiya (4824993)

“…Here, we propose the surprise-sensitive utility model, a reinforcement learning model that states that surprise decreases the outcome value, to explain how surprise affects subsequent decision making. …”